stock
Lyell Immunopharma Inc
NASDAQ | LYEL
13.23
USD
+0.00 ( +0.00%)
AT CLOSE (AS OF Jun 6, 2025)
$170M
MARKET CAP
-
P/E Ratio
-25
EPS
$54
52 Week High
$7.7
52 Week Low
LIFE SCIENCES
Sector
LYEL Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
LYEL Technicals
LYEL Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $61K |
| Total Revenue | $61K |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$359M |
| Selling General And Administrative | $52M |
| Research And Development | $172M |
| Operating Expenses | $359M |
| Investment Income Net | - |
| Net Interest Income | $24M |
| Interest Income | $24M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $20M |
| Income Before Tax | -$343M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$343M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$220M |
| Ebitda | -$201M |
| Net Income | -$343M |
Revenue & Profitability
Earnings Performance
LYEL Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $491M |
| Total Current Assets | $380M |
| Cash And Cash Equivalents At Carrying Value | $106M |
| Cash And Short Term Investments | $106M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $111M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $32M |
| Short Term Investments | $265M |
| Other Current Assets | $9.1M |
| Other Non Current Assets | - |
| Total Liabilities | $108M |
| Total Current Liabilities | $54M |
| Current Accounts Payable | $5.4M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $8M |
| Total Non Current Liabilities | $54M |
| Capital Lease Obligations | $59M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $59M |
| Other Current Liabilities | $40M |
| Other Non Current Liabilities | $3.3M |
| Total Shareholder Equity | $383M |
| Treasury Stock | - |
| Retained Earnings | -$1.3B |
| Common Stock | $29K |
| Common Stock Shares Outstanding | $261M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$162M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $20M |
| Capital Expenditures | $464K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $1.3M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $36M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$343M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $61K |
| Total Revenue | $61K |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$359M |
| Selling General And Administrative | $52M |
| Research And Development | $172M |
| Operating Expenses | $359M |
| Investment Income Net | - |
| Net Interest Income | $24M |
| Interest Income | $24M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $20M |
| Income Before Tax | -$343M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$343M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$220M |
| Ebitda | -$201M |
| Net Income | -$343M |
LYEL News
LYEL Profile
Lyell Immunopharma Inc Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Lyell Immunopharma, Inc., a T-cell reprogramming company, is dedicated to the development of T-cell therapies for patients with solid tumors. The company is headquartered in South San Francisco, California with additional offices in Seattle and Bothell, Washington.
NCNA 25.57%
$0.0496
PLUG 14.07%
$0.9941
APLD 14.10%
$14.57
TSLA 5.59%
$300.62
NVDA 1.57%
$142.19
LCID 1.41%
$2.16
DNN -0.62%
$1.61
NCL -80.59%
$0.262
AXDX -61.36%
$0.034
HCTI -3.03%
$0.0064
F 1.98%
$10.3
GNLN -7.14%
$0.0065
VERO 31.80%
$3.15
DTCK 33.33%
$0.8
GLYC -3.52%
$0.1916
LYT -16.78%
$0.0982
QBTS 10.93%
$18.27
FAAS 42.13%
$0.728
JWN 0.08%
$24.66
PLTR 4.06%
$124.78
BNAI 30.63%
$0.6035
RIOT 12.86%
$10.1464
BTG -1.61%
$3.67
RXRX 19.80%
$5.475
TGB 17.30%
$3.0499
MARA 7.09%
$15.935
BJDX 42.43%
$2.165
RIG 3.72%
$2.79
DFS -0.21%
$200.05
WULF 15.54%
$4.425
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
NVTS 4.38%
$6.315
SOFI 2.19%
$13.97
INTC 1.65%
$20.32
HIMS 6.31%
$56.0994
BTE 5.26%
$1.8
RGTI 5.51%
$11.49
KLTO 9.33%
$0.2133
AG -2.32%
$8.215
AAL 3.37%
$11.65
CAN 3.83%
$0.5997
QUBT 12.47%
$13.305
HOOD 3.57%
$75.1
EYEN 21.96%
$3.8294
NGD -1.73%
$4.815
AVGO -3.75%
$250.1701
AFMD -34.95%
$0.1815
RKLB 8.08%
$28.5878
IAG -2.54%
$7.485
GRAB 1.76%
$5.149
ENCP -19.79%
$0.077
AAPL 0.74%
$202.1215
SOUN 7.20%
$10.152
MLGO -8.40%
$1.145
AMZN 1.95%
$211.9688
NIO -0.79%
$3.5914
FNA 0.00%
$13.09
HL -1.63%
$6.345
CLF 6.83%
$7.585
BERY -2.93%
$67.58
CLSK 10.14%
$9.935
CHPT 10.80%
$0.7501
EXK -2.09%
$4.455
CRWV
3.08%
$139.21
CHGG 45.87%
$1.765
ABEV 1.17%
$2.4889
WBD 1.55%
$9.7996
TLRY 3.40%
$0.4014
ONDS 12.34%
$1.775
GOOGL 2.65%
$172.67
VALE -0.11%
$9.4893
IREN 9.44%
$9.795
HBAN 2.06%
$16.065
EQX -4.79%
$6.96
VEEE 6.96%
$2.46
PTN -44.65%
$0.0941
BAC 1.10%
$44.8669
HSDT 4.38%
$1.1899
FSM -2.09%
$7.245
CIFR 10.91%
$3.915
DOCU -18.88%
$75.3595
AMD 0.69%
$116.49
ZAPP -46.31%
$0.1548
MRVL 6.66%
$69.4995
SMCI 2.72%
$41.88
PCG -1.83%
$15.6379
NBIS 2.04%
$47.2424
LGMK 9.89%
$0.004
ACHR 6.14%
$9.935
UBER 1.02%
$85.5298
SBSW 3.04%
$6.6979
RIVN 0.98%
$13.915
SNAP 0.99%
$8.2811
ECDA -4.15%
$0.3375
PFE 1.55%
$23.4775
KHC -0.30%
$26.62
BTBT 9.79%
$2.6678
ELBM 14.62%
$1.1806
GOOG 2.57%
$174.18
NCNA 25.57%
$0.0496
PLUG 14.07%
$0.9941
APLD 14.10%
$14.57
TSLA 5.59%
$300.62
NVDA 1.57%
$142.19
LCID 1.41%
$2.16
DNN -0.62%
$1.61
NCL -80.59%
$0.262
AXDX -61.36%
$0.034
HCTI -3.03%
$0.0064
F 1.98%
$10.3
GNLN -7.14%
$0.0065
VERO 31.80%
$3.15
DTCK 33.33%
$0.8
GLYC -3.52%
$0.1916
LYT -16.78%
$0.0982
QBTS 10.93%
$18.27
FAAS 42.13%
$0.728
JWN 0.08%
$24.66
PLTR 4.06%
$124.78
BNAI 30.63%
$0.6035
RIOT 12.86%
$10.1464
BTG -1.61%
$3.67
RXRX 19.80%
$5.475
TGB 17.30%
$3.0499
MARA 7.09%
$15.935
BJDX 42.43%
$2.165
RIG 3.72%
$2.79
DFS -0.21%
$200.05
WULF 15.54%
$4.425
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
NVTS 4.38%
$6.315
SOFI 2.19%
$13.97
INTC 1.65%
$20.32
HIMS 6.31%
$56.0994
BTE 5.26%
$1.8
RGTI 5.51%
$11.49
KLTO 9.33%
$0.2133
AG -2.32%
$8.215
AAL 3.37%
$11.65
CAN 3.83%
$0.5997
QUBT 12.47%
$13.305
HOOD 3.57%
$75.1
EYEN 21.96%
$3.8294
NGD -1.73%
$4.815
AVGO -3.75%
$250.1701
AFMD -34.95%
$0.1815
RKLB 8.08%
$28.5878
IAG -2.54%
$7.485
GRAB 1.76%
$5.149
ENCP -19.79%
$0.077
AAPL 0.74%
$202.1215
SOUN 7.20%
$10.152
MLGO -8.40%
$1.145
AMZN 1.95%
$211.9688
NIO -0.79%
$3.5914
FNA 0.00%
$13.09
HL -1.63%
$6.345
CLF 6.83%
$7.585
BERY -2.93%
$67.58
CLSK 10.14%
$9.935
CHPT 10.80%
$0.7501
EXK -2.09%
$4.455
CRWV
3.08%
$139.21
CHGG 45.87%
$1.765
ABEV 1.17%
$2.4889
WBD 1.55%
$9.7996
TLRY 3.40%
$0.4014
ONDS 12.34%
$1.775
GOOGL 2.65%
$172.67
VALE -0.11%
$9.4893
IREN 9.44%
$9.795
HBAN 2.06%
$16.065
EQX -4.79%
$6.96
VEEE 6.96%
$2.46
PTN -44.65%
$0.0941
BAC 1.10%
$44.8669
HSDT 4.38%
$1.1899
FSM -2.09%
$7.245
CIFR 10.91%
$3.915
DOCU -18.88%
$75.3595
AMD 0.69%
$116.49
ZAPP -46.31%
$0.1548
MRVL 6.66%
$69.4995
SMCI 2.72%
$41.88
PCG -1.83%
$15.6379
NBIS 2.04%
$47.2424
LGMK 9.89%
$0.004
ACHR 6.14%
$9.935
UBER 1.02%
$85.5298
SBSW 3.04%
$6.6979
RIVN 0.98%
$13.915
SNAP 0.99%
$8.2811
ECDA -4.15%
$0.3375
PFE 1.55%
$23.4775
KHC -0.30%
$26.62
BTBT 9.79%
$2.6678
ELBM 14.62%
$1.1806
GOOG 2.57%
$174.18
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.